Rowe Bennetsen (hateclose00)

Staphylococcus aureus is a powerful pathogen that causes a wide range of infectious diseases and results in a high mortality rate in humans. Treating S. aureus-related infections is extremely difficult because of its ability to resist many antibiotics; therefore, developing an effective vaccine against this infection can be an alternative and promising approach. In this study, we evaluated the protective effects of a Hla-MntC-SACOL0723 multi-epitope protein (HMS) compared with HMS conjugated to polysaccharides 5 and 8 (CP5 and CP8) of S. Guadecitabine concentration aureus and CP5 and CP8 in a mouse sepsis model. To evaluate the type of induced immune response, specific IgG, and antibody isotypes (IgG1 and IgG2a) were determined using the ELISA method. The functional activity of these vaccine candidates was assessed by opsonophagocytosis. Mice were infected with S. aureus COL strain and evaluated for bacterial load in the kidney and spleen homogenates. Th1, Th2, and Th17-related cytokines in the spleen cell supernatants were assessed by flow cytometry. The therapeutic effect of specific anti-HMS protein IgG antibodies against S. aureus COL strain infection was evaluated by passive immunization. HMS recombinant protein induced a higher level of Th1, Th2, and Th17-related cytokines compared with conjugated molecules. Also, mice immunized with the HMS protein reduced the bacterial load in the kidney and spleen more than the one that received the conjugated molecules. Our study suggests that the HMS fusion protein and conjugate molecule vaccine candidates could be suitable candidates for the removal of S. aureus in the mouse sepsis model but HMS protein can be a more effective candidate.Gut microbiota-based choline metabolism produces trimethylamine (TMA), which is then further converted to the atherosclerosis-promoting metabolite trimethylamine-N-oxide (TMAO) by hepatic flavin-containing monooxygenases (FMOs) and TMAO plays an essential role in cardiovascular disease (CVD). Many Chinese herbal medicines had been used for the treatment of CVD. This study aimed to screen choline-degrading bacteria from healthy human feces and establish a platform in silico and in vitro approaches for screening TMA-lyase inhibitors from Chinese herbal medicines. Choline-degrading bacteria were screened from healthy human feces in basic salt medium using culture method. The isolated strains were identified as Klebsiella pneumoniae based on 16S rRNA and the presence of CutC gene. Structure of CutC choline lyase was obtained from the RCSB Protein Data Bank database, and the modeled structure was docked with natural compounds of Chinese herbal medicines origin using MOE. Further, we investigated the inhibitory effects of selected compounds by picric acid-toluene method using K. pneumoniae as bioassay indicator. We found that TMA level was significantly decreased when treated with β-sitosterol and resveratrol. This study initially demonstrates the inhibitory effect of β-sitosterol and resveratrol on the gut microbiota responsible for choline metabolism to TMA and sets up an inhibitor-screening platform for further experiments. It can be used as a model to evaluate herbal drug sources and their effects on the gut microbiota for cardiovascular disease. Helicobacter pylori infection occurs in 50% of the world's population and represents a major risk factor for chronic gastritis, gastroduodenal ulcer and gastric cancer in developed and developing countries. The distribution of H. pylori virulence factors is diverse and varies geographically, such as the CagA and VacA genes, which have revealed association with disease status. Some findings show increased frequencies of these diseases in O Le (a-b +) and A Le (a-b +) blood type individuals, but other studies not found any relationship between these blood groups and H. pylori infection. This study aimed to elucidate probable controversies described in the relationship between the ABH/Lewis